Akili, Inc.

The momentum for this stock is not very good. Akili, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Akili, Inc..
Log in to see more information.
AKLI Fundamental Data by TradingView

News

Akili (NASDAQ:AKLI) & Nevro (NYSE:NVRO) Critical Comparison
Akili (NASDAQ:AKLI) & Nevro (NYSE:NVRO) Critical Comparison

Ticker Report Akili (NASDAQ:AKLI - Get Free Report) and Nevro (NYSE:NVRO - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the...\n more…

Akili, Inc. (NASDAQ:AKLI) Sees Large Drop in Short Interest
Akili, Inc. (NASDAQ:AKLI) Sees Large Drop in Short Interest

Zolmax Akili, Inc. (NASDAQ:AKLI - Get Free Report) saw a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 271,400 shares, a decline of...\n more…

Akili, Inc. (NASDAQ:AKLI) Sees Large Decline in Short Interest
Akili, Inc. (NASDAQ:AKLI) Sees Large Decline in Short Interest

Ticker Report Akili, Inc. (NASDAQ:AKLI - Get Free Report) saw a significant decrease in short interest in the month of June. As of June 15th, there was short interest totalling 271,400 shares, a decrease of 56.5...\n more…

Analyzing Akili (NASDAQ:AKLI) and Tandem Diabetes Care (NASDAQ:TNDM)
Analyzing Akili (NASDAQ:AKLI) and Tandem Diabetes Care (NASDAQ:TNDM)

Ticker Report Akili (NASDAQ:AKLI - Get Free Report) and Tandem Diabetes Care (NASDAQ:TNDM - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based...\n more…

Financial Comparison: Akili (NASDAQ:AKLI) and Tandem Diabetes Care (NASDAQ:TNDM)
Financial Comparison: Akili (NASDAQ:AKLI) and Tandem Diabetes Care (NASDAQ:TNDM)

Zolmax Akili (NASDAQ:AKLI - Get Free Report) and Tandem Diabetes Care (NASDAQ:TNDM - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based...\n more…

Akili announces FDA authorization of EndeavorOTC
Akili announces FDA authorization of EndeavorOTC

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…